Alnylam Pharmaceuticals
ALNY
#697
Rank
โ‚น3.534 T
Marketcap
โ‚น26,474
Share price
-2.71%
Change (1 day)
-0.43%
Change (1 year)
Alnylam Pharmaceuticals Inc. is a biopharmaceutical company focused on the R&D and commercialization of RNA interference (RNAi) therapeutics for genetically defined diseases.

We have found no dividend yield history for this company